Strategic Expertise
Operational Excellence
Advancing Healthcare

DLRC is a dedicated consultancy team of highly qualified and experienced Regulatory Affairs professionals.

We work with clients, who range from Top 5 Pharma companies to SMEs, to develop and execute innovative regulatory strategies from early product development to post-licensing activities for medicines and medical devices.

We pride ourselves on our understanding of clients’ needs and our flexible, creative and pragmatic approach puts our clients and the patients they serve at the centre of everything we do.

Our Services

Partnership and collaboration

Working in partnership with Pharma, Biotech and MedTech companies, DLRC supports and facilitates the development of new medicines and medical devices to the benefit of patients in Europe, the US and beyond.

Contact us
DLRC Regulatory Affairs

Life-cycle product management

From scientific advice in early product development, to clinical trials, marketing authorisation applications and post-licensing activities, our highly qualified and experienced team can maximise value through life-cycle product management and ensure you, as a client make, the best-informed development decisions.

Our Services
DLRC life cycle product management

A forward-thinking consultancy, DLRC understands individual company’s unique requirements and finds creative and pragmatic solutions for all regulatory challenges.

How can DLRC help you maximise your products’ and company’s potential?

Contact us
DLRC Regulatory Affairs Professionals

Are you prepared for the new
Clinical Trials Regulation?

The EU Clinical Trials Regulation (CTR) entered into force on 31 January 2022 and is now mandatory for all new applications as of 31 January 2023.

Find out more

Awards

Find out more

Stay Informed

Sign up to our bimonthly newsletter for the latest news and industry insights

    Please check this box to submit the form and agree to communications from DLRC and the storage and handling of your data, in accordance with our Privacy Policy.

    Thank you for your submission.